Literature DB >> 15975055

Functional interactions of tau and their relevance for Alzheimer's disease.

Roland Brandt1, Julia Leschik.   

Abstract

Abnormalities in tau modification and tau aggregation are a characteristic histopathological hallmark of Alzheimer's disease (AD). However it is less clear, how tau pathology is linked to other factors, e.g. the formation of amyloid plaques, mutations in the presenilin gene, or the ApoE genotype that all have been shown to contribute to the disease. In this article, data reporting tau's interactions with other factors that may be relevant for AD and that have been obtained from various types of in vitro experiments, cell culture experiments and animal models are summarized and brought into a mechanistic framework. Evidences for functional links of these interactions to neurodegenerative events characteristic for AD are discussed and weighed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15975055     DOI: 10.2174/1567205043332054

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  17 in total

Review 1.  Tau-targeted treatment strategies in Alzheimer's disease.

Authors:  Jürgen Götz; Arne Ittner; Lars M Ittner
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

Review 3.  The Crosstalk Between Pathological Tau Phosphorylation and Mitochondrial Dysfunction as a Key to Understanding and Treating Alzheimer's Disease.

Authors:  Sanjib Guha; Gail V W Johnson; Keith Nehrke
Journal:  Mol Neurobiol       Date:  2020-08-26       Impact factor: 5.590

4.  Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.

Authors:  Wenjie Luo; Fei Dou; Anna Rodina; Sophorn Chip; Joungnam Kim; Qi Zhao; Kamalika Moulick; Julia Aguirre; Nian Wu; Paul Greengard; Gabriela Chiosis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-21       Impact factor: 11.205

5.  Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.

Authors:  Cai Zhiyou; Yan Yong; Sun Shanquan; Zhang Jun; Huang Liangguo; Yan Ling; Li Jieying
Journal:  Neurochem Res       Date:  2009-01-04       Impact factor: 3.996

6.  Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.

Authors:  M-L Selenica; H S Jensen; A K Larsen; M L Pedersen; L Helboe; M Leist; J Lotharius
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

Review 7.  Decoding the non-coding RNAs in Alzheimer's disease.

Authors:  Nicole Schonrock; Jürgen Götz
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

8.  MicroRNAs and the Regulation of Tau Metabolism.

Authors:  Sébastien S Hébert; Nicolas Sergeant; Luc Buée
Journal:  Int J Alzheimers Dis       Date:  2012-06-05

9.  4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal Neurogenesis.

Authors:  Hongchun Li; Wei Xu; Denian Wang; Liang Wang; Qiyao Fang; Xuemei Wan; Jiamei Zhang; Yiming Hu; Huifang Li; Jie Zhang; Zhen Yang; Chunqi Liu; Xiaocong Liu; Yonghai Wang; Bin Liu; Zhengtao Hu; Ying Zhao; Qian Bu; Hongbo Wang; Jingwei Tian; Yinglan Zhao; Xiaobo Cen
Journal:  J Neurosci       Date:  2021-06-07       Impact factor: 6.167

10.  What Renders TAU Toxic.

Authors:  Jürgen Götz; Di Xia; Gerhard Leinenga; Yee Lian Chew; Hannah Nicholas
Journal:  Front Neurol       Date:  2013-06-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.